IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 330.60K | 250.30K | 205.30K | 265.30K | 569.30K |
| Total Other Revenue | -- | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Revenue | 330.60K | 250.40K | 205.40K | 265.40K | 569.40K |
| Cost of Revenue | 602.20K | 609.00K | 1.33M | 1.35M | 1.53M |
| Gross Profit | -271.60K | -358.70K | -1.13M | -1.09M | -960.70K |
| SG&A Expenses | 2.97M | 2.62M | 3.31M | 4.66M | 6.51M |
| Depreciation & Amortization | 377.10K | 474.20K | 1.81M | 1.31M | 2.27M |
| Other Operating Expenses | 4.80M | 5.24M | 6.46M | 6.69M | 6.83M |
| Total Operating Expenses | 9.87M | 10.27M | 14.15M | 16.28M | 19.51M |
| Operating Income | -9.54M | -10.02M | -13.94M | -16.01M | -18.94M |
| Income Before Tax | -9.85M | -9.89M | -10.94M | -8.58M | -13.14M |
| Income Tax Expenses | -43.00K | -40.60K | -162.60K | -162.60K | -117.60K |
| Earnings from Continuing Operations | -9.80 | -9.85 | -10.77 | -8.42 | -13.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.80M | -9.85M | -10.77M | -8.42M | -13.02M |
| EBIT | -9.54M | -10.02M | -13.94M | -16.01M | -18.94M |
| EBITDA | -8.83M | -9.22M | -11.71M | -13.68M | -15.65M |
| EPS Basic | -0.21 | -0.16 | -0.80 | -0.34 | -2.56 |
| Normalized Basic EPS | -0.09 | -0.06 | -0.73 | -0.45 | -1.83 |
| EPS Diluted | -0.22 | -0.16 | -0.80 | -0.35 | -2.57 |
| Normalized Diluted EPS | -0.09 | -0.06 | -0.73 | -0.45 | -1.83 |
| Average Basic Shares Outstanding | 183.46M | 1.00B | 961.05M | 922.08M | 895.11M |
| Average Diluted Shares Outstanding | 183.46M | 1.00B | 961.06M | 922.09M | 895.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |